- [June 15, 2020]
SARS-CoV-2 antibody assays from numerous suppliers worldwide are currently being sold without corresponding internal quality controls - mainly due to the lack of available positive plasma on the market. The controls are important to assess laboratory precision and day-to-day assay performance of the testing systems.
To fill this gap, DiaMex GmbH (a sister company of #Biomex GmbH) has developed an Anti-SARS-CoV-2 IgG and IgM control to be used with several different assays. The controls
- are human plasma-based to mimic patient specimen encountered in a daily testing environment and provide a complete quality solution for SARS-CoV-2 #antibody testing
- react at an appropriate level within the analytical range of the assays with a high lot to lot consistency
- can be used as third party controls to verify systematic errors and satisfy regulatory guidelines for use of independent controls.
For further information please contact the staff at DiaMex: email@example.com